NanoVibronix, Inc.
USD1.90
+0.02 (+1.06%)
CEO
Doron Robert Besser
IPO Date
2015-05-28
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$1.84
Prev. Close
$1.88
Day Low
$1.77
Day High
$1.92
52W Low
$1.05
52W High
$162.50
Market Cap
$0.00B
Volume
0.10M
| 20,000 |
| $0.60 |
| 2 Jan 2025 | JACOB HAROLD | director, officer: Chief Medical Officer | A-Award | Acquired | 10,000 | $0.60 |
| 2 Jan 2025 | Goldstein Martin M | director | A-Award | Acquired | 23,000 | $0.60 |
| 2 Jan 2025 | BROWN STEPHEN RUSSELL | Chief Financial Officer | A-Award | Acquired | 50,000 | $0.60 |
| 2 Jan 2025 | FASHEK CHRISTOPHER M | director | A-Award | Acquired | 50,000 | $0.60 |
| 2 Jan 2025 | MIKA THOMAS | director | A-Award | Acquired | 20,000 | $0.60 |
| 26 Feb 2024 | JACOB HAROLD | director, officer: Chief Medical Officer | A-Award | Acquired | 6,667 | $0.90 |
| 26 Feb 2024 | MIKA THOMAS | director | A-Award | Acquired | 16,666 | $0.90 |
| 23 Feb 2024 | Ferguson Michael | director | A-Award | Acquired | 16,666 | $0.90 |